B: Well, we were in the midst of experiments aiming to use an animal virus to introduce new
genes into human cells and into bacterial cells.
And biotech firms might someday be able to exploit these bacteria as miniature factories for injecting proteins
directly into human cells.
In recent research published in the Journal of Biological Chemistry, Saint Louis University investigators report catching integrase, the part of retroviruses like HIV that is responsible for insertion of the viral
DNA into human cell DNA, in the presence of a drug designed to thwart it.
When
transplanted into human cells in the laboratory, the mammoth TRPV3 gene produced a protein that is less responsive to heat than an ancestral elephant version of the gene.
In a trial described in Nature Materials, the team showed they could deliver the nucleic acids DNA and siRNA
into human cells in the lab, using the nanoneedles.
Earlier this year, scientists in California determined that a protein called AXL may be how the Zika virus
gets into human cells.
By integrating the gp41 protein into the vaccine, researchers try to trigger the production of antibodies that would block the entrance of
HIV into human cells.
But researchers still have to find a safe and easy way to put an
EGS into human cells, a feat that could take several years of work.
After that was settled, gene therapists still had to find a suitable virus, or vector, to carry replacement genes
into human cells without inciting a damaging or deadly immune response.
The researchers put the twice - mutated p53 genes
back into human cells and found that they worked there too.
Estes, who works with virologist Jeffrey Lifson, has also developed a DNAscope to visualize this HIV DNA — called the provirus — which becomes
integrated into human cells and can persist for decades without being attacked by the immune system or antiretroviral (ARV) drugs.
A leaky gut that (a) allows Neu5Gc from food to enter the body for subsequent
incorporation into human cells, such as thyroid cells, and (b) creates either a systemic invasion of Neu5Gc - bearing gut pathogens, or a «metabolic endotoxemia» in which Neu5Gc - bearing cell wall components of gut bacteria enter the body, triggering formation of high - affinity anti-Neu5Gc antibodies.
A new gene is injected into an adenovirus vector, which is used to introduce the modified
DNA into a human cell.
Harris Wang of Columbia University told ScienceInsider that he will receive $ 500,000 from the Defense Advanced Research Projects Agency (DARPA) to engineer about 40 nonhuman metabolic
genes into human cells, enabling them to produce the nine essential amino acids that we now must get from our diet.
«Study identifies potent inhibitor of Zika
entry into human cells: Finding is a «stepping stone» toward development of new class of anti-virals.»
It's only possible to speculate why the measles virus would find an evolutionary advantage to being so rigid, but one hypothesis is that measles uses a more complex strategy to
get into human cells than influenza.
Beyond this, we could take the DNA repair abilities from Polypedilum vanderplanki, a fly whose larvae can survive complete desiccation and extremes of heat and cold, and transplant
them into human cells.
The former director of the Institute for Human Gene Therapy, he was widely regarded as the scientist most likely to crack the pesky vector problem: how to safely harness viruses as the Trojan horses that would carry new genes
into human cells to repair their DNA.
To prove that they do, Duesberg says, researchers should be able to create cancer in cell cultures by inserting human cancer genes
into human cells.
Kotton built a reporter gene that glowed green when the stem cells first expressed Nkx2 - 1, and Hawkins engineered the same gene
into human cells.
Integrase inhibitors (Merck's MK - 0518 and Gilead Sciences» GS 9137) prevent viral DNA from incorporating
itself into the human cell's chromosomes.
The authors focused on the approaches that have delivered the best outcomes in gene therapy so far: 1) direct in vivo administration of viral vectors, or the use of viruses to deliver the therapeutic genes
into human cells; and 2) the transfer of genetically engineered blood or bone marrow stem cells from a patient, modified in a lab, then injected back into the same patient.
Bartenschlager injected this «replicon,» which codes for HCV's nonstructural proteins but not its core or surface proteins,
into human cells.
«The successful development of technologies for rapid introduction of large DNA vectors
into human cell lines will enable the ability to engineer much more complex functionalities into human cell lines than are currently possible,» states the project's proposal page.
To demonstrate REPAIR's therapeutic potential, the team synthesized the pathogenic mutations that cause Fanconi anemia and X-linked nephrogenic diabetes insipidus, introduced
them into human cells, and successfully corrected these mutations at the RNA level.
While gene therapy has long been controversial, new successes and treatment methods (using disabled HIV to insert the genes
into human cells, for instance) open the door to experimentation with many diseases.